Akebia | Pioneering Hypoxia Inducible Factor (HIF) Therapies

Hypoxia inducible factor (HIF) enables the body’s adaptive physiologic response to altitude—and has great promise in the treatment of serious diseases.

Learn how we’re leading the way

So What is HIF?

HIF helps the body to adapt to conditions of low oxygen, similar to what is experienced at moderate altitude. Learn more about the potential therapeutic value of HIF.

ARE YOU A "HIFSTER"? JOIN OUR TEAM

Akebia is growing! See what being a HIFSTER is all about.

Our Pipeline

We're Pursuing indications in kidney disease and other serious conditions.

The Science of High Altitude

We're Exploring the Link Between Hypoxia and Treatment of Serious Diseases.

Recent Press Releases View All »

Tuesday, September 4, 2018Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Thursday, August 30, 2018Akebia Therapeutics to Participate in Upcoming Investor Conferences

Tuesday, August 28, 2018Akebia Therapeutics Appoints Cynthia Smith to Its Board of Directors

Community News View All »

Akebia 2018 Spring Conference Recap Monday, September 10, 2018 We care deeply about the work we do as we strive to make a positive difference for patients suffering from chronic kidney disease. There is always more to learn, and this spring’s conference season provided multiple opportunities to meet with and exchange thoughts and information with our colleagues and partners in the nephrology field.

JP Morgan Healthcare Conference, San Francisco, CA Friday, January 12, 2018 We’re happy to report a great week of meetings.

American Society of Nephrology, New Orleans, LA Wednesday, November 1, 2017 Akebia recently attended the American Society of Nephrology (ASN) in New Orleans.

Join Us View All »

Vice President, Medical Affairs

Marketing Manager

Sr. Manager, Business Development

Director, Marketing

Senior Research Associate, Cell Biology and Biochemistry

Manager, Quality Assurance GMP